In Vitro Response of Animal Arteries to Serum of Migraineurs

1979 ◽  
Vol 19 (4) ◽  
pp. 209-213
Author(s):  
G. Nattero ◽  
J. Franzone ◽  
F. Croce ◽  
D. Bisbocci ◽  
E. Genazzani
Keyword(s):  
Author(s):  
Tso-Chang Wu ◽  
Sameehan S. Joshi ◽  
Yee-Hsien Ho ◽  
Mangesh V. Pantawane ◽  
Subhasis Sinha ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2815
Author(s):  
Gang Ren ◽  
Xunzhen Zheng ◽  
Vandana Sharma ◽  
Joshua Letson ◽  
Andrea L. Nestor-Kalinoski ◽  
...  

Excessive myofibroblast activation, which leads to dysregulated collagen deposition and the stiffening of the extracellular matrix (ECM), plays pivotal roles in cancer initiation and progression. Cumulative evidence attests to the cancer-causing effects of a number of fibrogenic factors found in the environment, diseases and drugs. While identifying such factors largely depends on epidemiological studies, it would be of great importance to develop a robust in vitro method to demonstrate the causal relationship between fibrosis and cancer. Here, we tested whether our recently developed organotypic three-dimensional (3D) co-culture would be suitable for that purpose. This co-culture system utilizes the discontinuous ECM to separately culture mammary epithelia and fibroblasts in the discrete matrices to model the complexity of the mammary gland. We observed that pharmaceutical deprivation of nitric oxide (NO) in 3D co-cultures induced myofibroblast differentiation of the stroma as well as the occurrence of epithelial–mesenchymal transition (EMT) of the parenchyma. Such in vitro response to NO deprivation was unique to co-cultures and closely mimicked the phenotype of NO-depleted mammary glands exhibiting stromal desmoplasia and precancerous lesions undergoing EMT. These results suggest that this novel 3D co-culture system could be utilized in the deep mechanistic studies of the linkage between fibrosis and cancer.


1987 ◽  
Vol 31 (sa) ◽  
pp. 203-208 ◽  
Author(s):  
T. G. Clark ◽  
H. W. Dickerson ◽  
J. B. Gratzek ◽  
R. C. Findly

1988 ◽  
Vol 30 (1-6) ◽  
pp. 457-460 ◽  
Author(s):  
Chantal Dauphin-Villemant ◽  
François Leboulenger ◽  
Françoise Xavier ◽  
Hubert Vaudry

1995 ◽  
Vol 59 (3) ◽  
pp. 242-246 ◽  
Author(s):  
K Vickery ◽  
A Pajkos ◽  
Y Cossart

Steroids ◽  
1975 ◽  
Vol 25 (3) ◽  
pp. 379-386 ◽  
Author(s):  
E. Nieschlag ◽  
W. Tekook ◽  
K.H. Usadel ◽  
H.K. Kley ◽  
H.L. Krüskemper

1990 ◽  
Vol 48 (1) ◽  
pp. 7-14 ◽  
Author(s):  
Domenico Del Principe ◽  
Adriana Menichelli ◽  
Stefano Di Giulio ◽  
Walter De Matteis ◽  
Massimo Giordani ◽  
...  

PEDIATRICS ◽  
1983 ◽  
Vol 71 (1) ◽  
pp. 118-119
Author(s):  
HOWARD M. KELFER ◽  
WILLIAM D. SINGER ◽  
ROBERT N. REYNOLDS

Patients with Duchenne muscular dystrophy (DMD) are susceptible to numerous adverse intraoperative and postoperative side effects of anesthetic agents. These include: hyperthermia and hyperkalemia,1,2 systemic acidosis,3 cardiac abnormalities (tachycardia, arrhythmia, arrest),2-5 rhabdomyolysis,2-6 as well as death.2,5 These clinical and laboratory findings are similar to those associated with malignant hyperthermia (MH).7,8 Until this time no one has confirmed the association of MH, as reflected by these clinical phenomena, in a patient with DMD. We present a patient who manifested many features of MH immediately following confirmatory muscle biopsy for DMD under general anesthesia. In vitro response to testing of a muscle biopsy specimen was consistent with a diagnosis of malignant hyperthermia.


Sign in / Sign up

Export Citation Format

Share Document